Richwood Investment Advisors, LLC Biomarin Pharmaceutical Inc Transaction History

Richwood Investment Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	SELL	$82.16 - $96.94 $6,572 - $7,755	-80 Reduced 3.26%	2,375 $201,000
Q2 2022 Jul 22, 2022	BUY	$71.48 - $86.85 $175,483 - $213,216	2,455 New	2,455 $203,000
Q1 2022 Apr 28, 2022	SELL	$74.28 - $92.69 $182,357 - $227,553	-2,455 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$71.72 - $91.47 $176,072 - $224,558	2,455 New	2,455 $217,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Richwood Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Richwood Investment Advisors, LLC with notifications on news.